Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2006, p. 2587-2589, Vol. 44, No. 7
0095-1137/06/$08.00+0 doi:10.1128/JCM.00265-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Departments of Clinical Virology,1 Infectious Diseases, Göteborg University, Göteborg, Sweden2
Received 6 February 2006/ Returned for modification 20 March 2006/ Accepted 14 May 2006
The COBAS AMPLICOR hepatitis B virus assay targets a conserved region of the genome and is widely used to monitor treatment of hepatitis B in order to identify emerging resistance. However, the assay failed to recognize increasing viremia levels when YMDD mutations were paralleled by mutations in the segment targeted by the COBAS AMPLICOR probe.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»